BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Los Alamos National Laboratory Spin-out, CIVA Gets New CEO


7/6/2007 10:17:31 AM

LOS ALAMOS, N.M.--(BUSINESS WIRE)--The Los Alamos National Laboratory (LANL) spin-out CIVA (the Company for Information Visualization and Analysis http://www.civaglobal.com), exclusively tasked with making the innovative new EpiCast flu and pandemic computer modeling tool available to government and corporate entities worldwide, has named John R. Grizz Deal its president and chief executive officer.

Perhaps the most far-reaching public health tool ever to come from behind the doors of the U.S. government's famously remote national center of scientific research, EpiCast is the basis for U.S. federal government mitigation and response planning for the Department of Homeland Security and the White House. Created by LANL's Dr. Tim Germann, the program simulates in detail, the spread of "Avian Flu" and other natural or manmade (terrorist) airborne pathogens. One of its unique features is EpiCast's ability to provide custom mitigation strategies to offset the pathogen's predicted impact on the studied community - whether that community is a private company, small city or entire nation.

Named as one of Fast Company Magazine's "Fast 50" companies in 2007, CIVA is headquartered in New Mexico. According to L. Robert Libutti, Ph.D., chairman of the board of CIVA, the company was formed in 2005 to bring sophisticated but often hard to use, business analytics and information visualization tools into the day-to-day lives of business decision-makers.

Deal has over 20 years of experience in startups, fast growing ventures, and acquisitions. He is managing director at Purple Mountain Ventures, serving large and small international firms on product development, capital expansion, and marketing. In addition to working with CIVA, Deal is currently serving as Entrepreneur in Residence for the NNSA at Technology Ventures Corporation as well as an advisor to Altira Group, the premier North American fund focused on energy-related ventures.

Deal was previously Visiting Entrepreneur at LANL. He has raised over $100 million for early stage firms, is the former chief marketing officer for Space Imaging, and also the founder and former CEO of LizardTech, one of the more successful LANL spin-outs. Deal holds graduate and undergraduate degrees from Texas A&M University.

Photo of Deal is available via Public Affairs: Deborah@civaglobal.com or phone: 407-774-1505.

www.civaglobal.com

Contact: For CIVA, Los Alamos Public Affairs Contact: Deborah Blackwell, APR, 407-774-1505

Source: CIVA



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES